WeVote

Bill

Bill

SB 2549

Opioids - As enacted, adds that a healthcare provider who subcontracts through the contracted healthcare vendor with the department of correction may prescribe a buprenorphine product for the treatment of opioid use disorder if other certain listed criteria are met. - Amends TCA Title 53 and Title 63.

114th Regular Session (2025-2026)

Tennessee authorizes subcontracted correctional healthcare providers to prescribe buprenorphine for incarcerated individuals with opioid use disorder when specified criteria are met.

Pub. Ch. 677
0
WeVote Research Nonpartisan
Bill Summary · SB 2549

Legislative bill overview

SB 2549 expands buprenorphine prescribing authority in Tennessee correctional facilities by allowing healthcare providers who subcontract through the Department of Correction's contracted vendors to prescribe buprenorphine for opioid use disorder treatment, provided they meet specified criteria. The bill amends Tennessee Code Annotated Titles 53 and 63 to implement these changes.

Why is this important

Opioid use disorder affects incarcerated populations at rates significantly higher than the general public, and buprenorphine is an evidence-based medication that reduces cravings, prevents overdose, and improves treatment outcomes. Expanding access to this medication within correctional settings can reduce recidivism, improve public health outcomes post-release, and address the opioid crisis comprehensively.

Potential points of contention

  • Implementation complexity: The "certain listed criteria" referenced in the bill's language are not detailed in this summary, creating uncertainty about prescribing standards, provider qualifications, and oversight mechanisms
  • Cost and resource allocation: Expanding medication access requires funding for drugs, training, and monitoring; unclear whether existing budgets will accommodate these expenses or if new appropriations are needed
  • Coordination with community providers: Ensuring continuity of care when incarcerated individuals are released requires coordination with community health providers that may not be established, potentially limiting treatment effectiveness

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.